Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Kindly MD ( (NAKA) ) is now available.
On September 15, 2025, Kindly MD, Inc. informed shareholders about filing a Form S-3 on September 12, 2025, which may lead to increased share price volatility. The company emphasized its commitment to its long-term vision and highlighted its strategy to build a Bitcoin-denominated treasury and invest in Bitcoin-focused companies. Kindly MD has achieved significant milestones, including raising $742 million, establishing a 5,700+ BTC treasury, and launching a $5 billion ATM program. The company aims to capitalize on Bitcoin’s mainstream acceptance and expand access to Bitcoin through publicly-traded Bitcoin treasury companies, ultimately enhancing liquidity and shareholder value.
The most recent analyst rating on (NAKA) stock is a Hold with a $2.50 price target. To see the full list of analyst forecasts on Kindly MD stock, see the NAKA Stock Forecast page.
Spark’s Take on NAKA Stock
According to Spark, TipRanks’ AI Analyst, NAKA is a Neutral.
The overall stock score is driven primarily by significant financial challenges, including declining revenues and profitability issues. Technical analysis indicates bearish momentum, and valuation metrics are unattractive due to negative earnings. The lack of earnings call data and corporate events means these factors do not influence the score.
To see Spark’s full report on NAKA stock, click here.
More about Kindly MD
Kindly MD, Inc. operates in the healthcare and financial services industry, focusing on personalized healthcare solutions and Bitcoin-related financial services. The company leverages advanced data analytics and integrated treatment protocols in healthcare while aiming to establish itself as a leading Bitcoin-native financial institution.
Average Trading Volume: 3,334,033
Technical Sentiment Signal: Sell
For a thorough assessment of NAKA stock, go to TipRanks’ Stock Analysis page.